Human IL13RA1/CD213A1/CT19 ORF/cDNA clone-Lentivirus plasmid (NM_001560.2)

Cat. No.: pGMLP001956
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human IL13RA1/CD213A1/CT19 Lentiviral expression plasmid for IL13RA1 lentivirus packaging, IL13RA1 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to IL-13Ra1/IL13RA1/CD213a1/IL13RA1/CD213A1 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Total Price: $659.52
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMLP001956
Gene Name IL13RA1
Accession Number NM_001560.2
Gene ID 3597
Species Human
Product Type Lentivirus plasmid (overexpression)
Insert Length 1284 bp
Gene Alias CD213A1,CT19,IL-13Ra,NR4
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGAGTGGCCGGCGCGGCTCTGCGGGCTGTGGGCGCTGCTGCTCTGCGCCGGCGGCGGGGGCGGGGGCGGGGGCGCCGCGCCTACGGAAACTCAGCCACCTGTGACAAATTTGAGTGTCTCTGTTGAAAACCTCTGCACAGTAATATGGACATGGAATCCACCCGAGGGAGCCAGCTCAAATTGTAGTCTATGGTATTTTAGTCATTTTGGCGACAAACAAGATAAGAAAATAGCTCCGGAAACTCGTCGTTCAATAGAAGTACCCCTGAATGAGAGGATTTGTCTGCAAGTGGGGTCCCAGTGTAGCACCAATGAGAGTGAGAAGCCTAGCATTTTGGTTGAAAAATGCATCTCACCCCCAGAAGGTGATCCTGAGTCTGCTGTGACTGAGCTTCAATGCATTTGGCACAACCTGAGCTACATGAAGTGTTCTTGGCTCCCTGGAAGGAATACCAGTCCCGACACTAACTATACTCTCTACTATTGGCACAGAAGCCTGGAAAAAATTCATCAATGTGAAAACATCTTTAGAGAAGGCCAATACTTTGGTTGTTCCTTTGATCTGACCAAAGTGAAGGATTCCAGTTTTGAACAACACAGTGTCCAAATAATGGTCAAGGATAATGCAGGAAAAATTAAACCATCCTTCAATATAGTGCCTTTAACTTCCCGTGTGAAACCTGATCCTCCACATATTAAAAACCTCTCCTTCCACAATGATGACCTATATGTGCAATGGGAGAATCCACAGAATTTTATTAGCAGATGCCTATTTTATGAAGTAGAAGTCAATAACAGCCAAACTGAGACACATAATGTTTTCTACGTCCAAGAGGCTAAATGTGAGAATCCAGAATTTGAGAGAAATGTGGAGAATACATCTTGTTTCATGGTCCCTGGTGTTCTTCCTGATACTTTGAACACAGTCAGAATAAGAGTCAAAACAAATAAGTTATGCTATGAGGATGACAAACTCTGGAGTAATTGGAGCCAAGAAATGAGTATAGGTAAGAAGCGCAATTCCACACTCTACATAACCATGTTACTCATTGTTCCAGTCATCGTCGCAGGTGCAATCATAGTACTCCTGCTTTACCTAAAAAGGCTCAAGATTATTATATTCCCTCCAATTCCTGATCCTGGCAAGATTTTTAAAGAAATGTTTGGAGACCAGAATGATGATACTCTGCACTGGAAGAAGTACGACATCTATGAGAAGCAAACCAAGGAGGAAACCGACTCTGTAGTGCTGATAGAAAACCTGAAGAAAGCCTCTCAGTGA
ORF Protein Sequence MEWPARLCGLWALLLCAGGGGGGGGAAPTETQPPVTNLSVSVENLCTVIWTWNPPEGASSNCSLWYFSHFGDKQDKKIAPETRRSIEVPLNERICLQVGSQCSTNESEKPSILVEKCISPPEGDPESAVTELQCIWHNLSYMKCSWLPGRNTSPDTNYTLYYWHRSLEKIHQCENIFREGQYFGCSFDLTKVKDSSFEQHSVQIMVKDNAGKIKPSFNIVPLTSRVKPDPPHIKNLSFHNDDLYVQWENPQNFISRCLFYEVEVNNSQTETHNVFYVQEAKCENPEFERNVENTSCFMVPGVLPDTLNTVRIRVKTNKLCYEDDKLWSNWSQEMSIGKKRNSTLYITMLLIVPVIVAGAIIVLLLYLKRLKIIIFPPIPDPGKIFKEMFGDQNDDTLHWKKYDIYEKQTKEETDSVVLIENLKKASQ

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Biosimilar GMP-Bios-ab-661 Pre-Made Eblasakimab biosimilar, Whole mAb, Anti-IL13RA1 Antibody: Anti-CD213A1/CT19/IL-13Ra/NR4 therapeutic antibody
    Target Antibody GM-Tg-g-T95961-Ab Anti-I13R1/ IL13RA1/ CD213A1 monoclonal antibody
    Target Antigen GM-Tg-g-T95961-Ag IL13RA1 VLP (virus-like particle)
    ORF Viral Vector pGMLP001956 Human IL13RA1 Lentivirus plasmid
    ORF Viral Vector vGMLP001956 Human IL13RA1 Lentivirus particle


    Target information

    Target ID GM-T95961
    Target Name IL-13Ra1/IL13RA1/CD213a1
    Gene Group Identifier
    （Target Gene ID in Homo species)         		3597
    Gene ID 100055312 (Equus caballus), 101091351 (Felis catus), 16164 (Mus musculus), 252963 (Rattus norvegicus)
    3597 (Homo sapiens), 403623 (Canis lupus familiaris), 407110 (Bos taurus), 710986 (Macaca mulatta)
    Gene Symbols & Synonyms IL13RA1,Il13ra1,NR4,Il13ra,CD213a1,IL-13r[a],IL-13R-alpha-1,CT19,CD213A1,IL-13Ra
    Target Alternative Names CD213A1,CD213a1,CT19,Cancer/testis antigen 19 (CT19),IL-13 receptor subunit alpha-1,IL-13R subunit alpha-1,IL-13R-alpha-1,IL-13RA1,IL-13Ra,IL-13Ra1,IL-13r[a],IL13RA1,Il13ra,Il13ra1,Interleukin-13 receptor subunit alpha-1,NR4
    Uniprot Accession O09030,P78552
    Additional SwissProt Accessions: O09030,P78552
    Uniprot Entry Name
    Protein Sub-location Transmembrane Protein
    Category Therapeutics Target, Immuno-oncology Target, INN Index
    Disease cancer
    Disease from KEGG Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Pathways in cancer
    Gene Ensembl ENSECAG00000019115, ENSMUSG00000017057, ENSG00000131724, ENSCAFG00845019238, ENSBTAG00000019338, ENSMMUG00000053844
    Target Classification Cytokine Receptor, Checkpoint-Immuno Oncology, Tumor-associated antigen (TAA)


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.